Revvity Announces FDA Clearance for First Automated Free Testosterone Test

BusinesswireJan 10 21:00

Bernstein Downgrades Revvity(RVTY.US) to Hold Rating, Cuts Target Price to $130

Futu NewsJan 10 20:34 · Ratings

Express News | Revvity Inc: Agreement Provides for a $1.5 Bln Committed Unsecured Revolving Credit Facility Available Through Jan 7, 2030

BreakingsJan 8 05:40

Express News | Revvity Inc: Entered Into Credit Agreement With Revvity and Revvity Health Sciences, Inc

BreakingsJan 8 05:40

Bernstein Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $145

Futu NewsJan 7 14:31 · Ratings

Bernstein Remains a Buy on Revvity (RVTY)

TipRanksJan 7 14:06 · Ratings